ESC 365 - Clinical factors related to successful or unsuccessful cardioversion in the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial

EHRA Premium Access

Clinical factors related to successful or unsuccessful cardioversion in the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial

Session: Poster session 3 - Atrial fibrillation - Clinical

Topic: Cardioversion and Defibrillation

Speaker: Professor G. Lip (Liverpool, GB)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Professor Gregory Yh Lip

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)

100 presentations

9 followers

39 more presentations in this session

Determinants of progression of persistent to permanent atrial fibrillation - data from the RACE 3 study

Speaker: Doctor R. De With (Groningen, NL)

The electrocardiographic and echocardiographic factors affecting infarct volume in acute ischaemic stroke

Speaker: Doctor D. Ranganathan (Montreal, CA)

Impact of incomplete revascularization in atrial fibrillation patients undergoing percutaneous coronary intervention: the afcas registry

Speaker: Associate Professor M. Proietti (Milan, IT)

Cryptogenic stroke is associated with atrial fibrosis similar to atrial fibrillation

Speaker: Professor N. Akoum (Seattle, US)

Do we follow the recommendation of anticoagulation withdrawal after electrical cardioversion, in patients with atrial fibrillation?

Speaker: Doctor M. Vidal Burdeus (Barcelona, ES)

Access the full session

Poster session 3 - Atrial fibrillation - Clinical

Speakers: Professor G. Lip, Doctor R. De With, Doctor D. Ranganathan, Associate Professor M. Proietti, Professor N. Akoum...

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources